| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 120.19B | 85.54B | 94.96B | 88.27B | 163.95B |
| Gross Profit | 120.19B | 85.54B | 94.96B | 80.06B | 163.95B |
| EBITDA | 13.93B | 17.04B | 3.28B | 1.85B | 10.38B |
| Net Income | 9.52B | 10.56B | 5.65B | -324.64M | 5.95B |
Balance Sheet | |||||
| Total Assets | 527.99B | 508.35B | 459.73B | 424.73B | 499.80B |
| Cash, Cash Equivalents and Short-Term Investments | 16.63B | 158.31B | 10.30B | 10.97B | 18.74B |
| Total Debt | 67.77B | 13.97B | 15.43B | 17.96B | 27.46B |
| Total Liabilities | 408.62B | 395.68B | 357.55B | 327.24B | 397.71B |
| Stockholders Equity | 109.69B | 103.26B | 93.25B | 86.02B | 92.71B |
Cash Flow | |||||
| Free Cash Flow | 28.16B | 9.91B | 15.86B | 11.31B | 9.12B |
| Operating Cash Flow | 28.56B | 10.35B | 16.29B | 11.71B | 9.56B |
| Investing Cash Flow | -1.88B | -18.56B | -14.83B | -6.80B | -15.57B |
| Financing Cash Flow | -16.58B | 4.62B | 999.20M | -12.20B | 14.01B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | HK$80.43B | 2.48 | 29.19% | 1.81% | 11.51% | 250.65% | |
68 Neutral | HK$43.59B | 6.52 | 10.97% | 5.22% | 3.44% | 15.71% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
65 Neutral | HK$10.92B | 18.91 | 5.60% | ― | 39.13% | 37.16% | |
64 Neutral | HK$55.22B | 4.62 | 8.96% | 3.22% | 9.10% | -7.65% | |
57 Neutral | HK$71.74B | 10.15 | 5.58% | 2.66% | 14.46% | 25.89% | |
55 Neutral | HK$20.47B | 14.26 | 5.72% | ― | 8.41% | 72.89% |